CVE-2023-38956
CVE-2023-38956 is a high-severity vulnerability in Zkteco Bioaccess Ivs with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.
Key facts
- Severity: High (CVSS 3.x base score 7.5)
- EPSS exploit prediction: 1% (45th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-22
- Affected product: Zkteco Bioaccess Ivs
- Published:
- Last modified:
Description
A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.
Frequently asked questions
- What is CVE-2023-38956?
- A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.
- How severe is CVE-2023-38956?
- CVE-2023-38956 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
- Is CVE-2023-38956 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (45th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-38956?
- CVE-2023-38956 affects Zkteco Bioaccess Ivs. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-38956?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2023-38956 published?
- CVE-2023-38956 was published on 2023-08-03 and last updated on 2026-07-09.
References
Affected products (1)
- cpe:2.3:a:zkteco:bioaccess_ivs:3.3.1:*:*:*:*:*:*:*
More vulnerabilities in Zkteco Bioaccess Ivs
- CVE-2023-38954 — Critical (CVSS 9.8): ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
- CVE-2023-38955 — High (CVSS 7.5): ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices,…
- CVE-2023-38958 — Medium (CVSS 5.3): An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open…
All CVEs affecting Zkteco Bioaccess Ivs →
Other CWE-22 (Path Traversal) vulnerabilities
- CVE-2026-48282 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted…
- CVE-2026-54917 — Critical (CVSS 10.0): SeaweedFS is a distributed storage system for object storage (S3), file systems, and Iceberg tables. Prior to 4.30, the…
- CVE-2026-11429 — Critical (CVSS 10.0): Two endpoints in the Vault Service ScriptsController, shared by Altium Enterprise Server and Altium 365, accept file…
- CVE-2026-34909 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit a Path Traversal vulnerability found in UniFi OS devices to…
- CVE-2026-7411 — Critical (CVSS 10.0): In Eclipse BaSyx Java Server SDK versions prior to 2.0.0-milestone-10, inadequate path normalization in the Submodel…
- CVE-2026-36767 — Critical (CVSS 10.0): A path traversal vulnerability in the /content/images/add endpoint of shopizer v3.2.5 allows attackers write arbitrary…